Limited studies have shown that patients with cancer infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) have more severe disease than the general population, with higher rates of serious illness and death in this population and other immunocompromised populations. Children are susceptible to SARS‐CoV‐2 infection, but clinical severity of the infection is significantly less than in adults. However, there is a paucity of data describing SARS‐CoV‐2 infection in pediatric patients with cancer. Here we report our experience with six pediatric oncology patients at our institution who tested positive for SARS‐CoV‐2 infection.
Read the full article here.